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CASE STUDY
Vitamin D deficiency and fatigue:  
an unusual presentation
Kevin Johnson and Maryam Sattari*
Abstract 
Fatigue is a vague but common complaint that is poorly characterized by physicians as well as patients. While fatigue 
may result from a number of different etiologies, at the present time, a comprehensive approach to each patient with 
fatigue does not include routine measurement of serum vitamin D levels. A 61-year-old man was evaluated for exces-
sive daytime fatigue. No features characteristic for depression, sleep apnea, or narcolepsy were present. A compre-
hensive work-up, including thyroid function tests and testosterone levels, did not reveal any abnormalities. However, 
serum 25-hydroxyvitamin D level was low, at 18.4 ng/mL. Vitamin D supplementation was initiated. At follow-up in 
3 and 12 months, the patient reported complete resolution of daytime fatigue, corresponding to an increase in his 
vitamin D levels. Possible mechanisms for clinical improvement include effects of vitamin D on components of inflam-
matory cascades, including tumor necrosis factor-alpha and prostaglandin D2, which result in decrease in central 
nervous system homeostatic sleep pressure. While more research is needed to determine if patients presenting with 
fatigue should be routinely screened for vitamin D deficiency, clinicians should consider obtaining vitamin D levels in 
patients with unexplained fatigue, nonspecific musculoskeletal pain, and risk factors for vitamin D deficiency.
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Background
Fatigue is a vague but common complaint that is poorly 
characterized by physicians as well as patients. While 
fatigue may result from a number of different etiologies, 
at the present time, a comprehensive approach to each 
patient with fatigue does not include routine measure-
ment of serum vitamin D levels. Vitamin D refers to a 
group of fat-soluble secosteroid hormones, and is typi-
cally ingested in dietary sources or manufactured in the 
skin after exposure to sunlight (Holick 2007). Increasing 
evidence suggests that vitamin D has many roles beyond 
its classically described effects on calcium homeostasis 
and bone health (Holick 2007). Research suggests pos-
sible associations between suboptimal levels of vitamin 
D and development of various diseases, including pul-
monary disorders (Black and Scragg 2005; Sita-Lumsden 
et  al. 2007; Camargo et  al. 2007; Devereux et  al. 2007; 
Litonjua and Weiss 2007) chronic rhinitis (Abuzeid et al. 
2012), tonsillar hypertrophy, (Nunn et  al. 1986; Reid 
et al. 2011), metabolic syndrome (Botella-Carretero et al. 
2007), type 2 diabetes (Mattila et al. 2007), hypertension 
(Forman et  al. 2007), cancers of the breast, colon, and 
prostate (Garland et al. 2006), poor stress resilience (Bra-
cha et  al. 2004), depression (Berk et  al. 2007), and cog-
nitive decline (Przybelski and Binkley 2007). Vitamin D 
appears to be necessary for skeletal muscle as well and its 
deficiency has been associated with nonspecific musculo-
skeletal pain (Plotnikoff and Quigley 2003), chronic pain 
(Turner et al. 2008), low back pain (Lotfi et al. 2007), and 
myopathy (Boltan et  al. 2007; Goldstein 2007; Prabhala 
et al. 2000). Some researchers have even suggested a link 
between vitamin D deficiency and all-cause mortality 
(Giovannucci 2007).
Vitamin D also has immunomodulatory activities (Hol-
ick 2007). Deficiency of vitamin D might be associated 
with diseases of immune dysregulation, one manifesta-
tion of which could be excessive daytime sleepiness (Zit-
terman and Gummert 2010; Hoeck and Pall 2011). We 
present a case of daytime fatigue in an otherwise healthy 
male who was found to be vitamin D deficient.
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Case presentation
A 61-year-old Caucasian man presented to primary 
care office with complaint of fatigue and daytime sleepi-
ness, especially in the afternoons. His symptoms began 
gradually 2–3  months prior to presentation, insidiously 
worsening to the point that he began having functional 
difficulties with his normal tasks at work in the after-
noons. He reported napping almost daily after work and 
even skipping some of his regular exercise sessions due to 
fatigue. He denied changes in his weight, new familial or 
occupational stressors, difficulty falling asleep, snoring, 
apnea, sleep disruptions, nocturnal awakenings, depres-
sion, or anxiety. In fact, his review of symptoms was 
only positive for chest pain that was worse in the after-
noon when he felt tired. He reported good sleep hygiene 
and was able to get his customary 7–8  h of sleep each 
night. Before the onset of his symptoms, he had worked 
fulltime and exercised on an almost daily basis, without 
experiencing any difficulties. His past medical history 
was only significant for colon cancer, in remission since 
surgical resection and completion of systemic adjuvant 
chemotherapy in 2005 (7 years prior to presentation). He 
did not take any prescription medications and denied use 
of tobacco products, alcohol, or recreational drugs.
Physical exam revealed a pleasant male in no dis-
tress. Vital signs were within normal limits. His body 
mass index was 28. No significant abnormalities were 
detected on complete physical exam. Laboratory data, 
including thyroid stimulating hormone, liver function 
tests, and renal indices, were normal (Table  1). EKG 
and stress echocardiogram were normal. In absence of a 
common etiology explaining patient’s symptoms, serum 
25-hydroxy vitamin D level was obtained and found to 
be low at 18.4 (normal range 30–80 ng/mL). Vitamin D 
replacement was initiated with ergocholecalciferol 50,000 
international units (IU) weekly for 8 weeks, followed by 
vitamin D 1000 IU daily.
Patient reported improvement of his fatigue and day-
time sleepiness within 2 weeks of initiation of vitamin D 
supplementation and complete resolution of his symp-
toms within 3 months of vitamin D initiation. In follow-
up visit in 3 months, he reported being able to perform 
his previous daily routine without difficulty. In addition 
to working full-time, he had resumed his exercise routine 
(3 sessions of resistance training and at least 6 sessions 
of 30–60  min of cardiovascular training a week) with-
out experiencing any limitations. He denied chest pain 
or daytime napping. He stated that—aside from initiat-
ing vitamin D supplementation—no other circumstances 
in his life had changed since his initial evaluation: there 
had been no interval changes in other medications, diet, 
social activities, caffeine use, stress level, or work. He 
continues to feel well and remains completely symptom-
free to date. His repeat 25-hydroxy vitamin D levels were 
27.2 ng/mL after 3 months of vitamin D supplementation 
and 32.2 ng/mL after 12 months (Table 2).
Discussion
The exact mechanism for the improvement in this 
patient’s fatigue after identification and treatment of vita-
min D deficiency is not known. To our knowledge, this is 
the second reported case of daytime fatigue and sleepi-
ness resolving upon remediation of vitamin D deficiency. 
McCarty has previously reported a case of excessive day-
time sleepiness and musculoskeletal pain in a 28-year-old 
African American female that improved with replace-
ment of vitamin D (McCarty 2010). This patient under-
went an overnight polysomnogram (PSG) before and 
after vitamin D repletion (McCarty 2010). While a full 
sleep evaluation before vitamin D repletion revealed the 
presence of heavy daytime napping and pervasive fatigue, 
the PSG did not show evidence of sleep disordered 
breathing or a sleep-related movement disorder (McCa-
rty 2010). Post-replacement PSG did not show a decrease 
in episodes and duration of wake after sleep onset or 
an improvement in sleep continuity, but did reveal an 
Table 1 Patient’s lab results on presentation
Lab Value Reference range
White blood cell 5.2 4.0–10.0 thousands/cu mm
Hemoglobin 13.9 13.0–16.0 g/dL
Sodium 142 136–145 mmol/L
Potassium 4.0 3.3–5.1 mmol/L
CO2 28 22–30 mmol/L
BUN 17 6–20 mg/dL
Creatinine 0.99 0.80–1.20 mg/L
Glucose 92 65–99 mg/dL
AST 14 0–37 U/L
ALT 15 0–41 U/L
Total CPK 128 30–170 U/L
Erythrocyte sedimentation rate 10 0–10 mm/h
Vitamin B12 1031 243–846 pg/mL
TSH 2.96 0.27–4.20 mL U/L
Testosterone free 47 47–244 pg/mL
CEA 2.1 0.0–4.3 ng/mL
Serum 25-hydroxy vitamin D 18.3 >29 ng/mL
Table 2 Patient’s serum 25-hydroxy vitamin D levels
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interval decrease in stage N3 sleep, suggesting a reduc-
tion in homeostatic sleep pressure following vitamin D 
replacement (McCarty 2010).
McCarty postulated that vitamin D deficiency may 
contribute to symptoms of sleepiness via components 
of inflammatory cascades, including known sleep regu-
lating substances (McCarty et  al. 2012). For example, 
there is an inverse relationship between levels of tumor 
necrosis factor-alpha (TNF-α) and serum 25-hydroxyvi-
tamin D (Fig.  1) (Peterson and Heffernan 2008). TNF-α 
has been implicated in the sleepiness associated with 
obstructive sleep apnea (Peterson and Heffernan 2008; 
Churchill et al. 2008). Vitamin D deficiency has also been 
associated with upregulation of nuclear factor kappa-B 
(NFĸB) (Jablonski et  al. 2011), which is responsible for 
the regulation of numerous substances known to exert 
homeostatic sleep pressure, including prostaglandin D2 
(Chen et al. 1999; Krueger et al. 2009). Prostaglandin D2 
functions as a physiologic regulator of sleep and affects 
the central nervous system homeostatic sleep pressure 
(Fig. 1) (McCarty et al. 2012).
Interestingly, the only identifiable potential risk fac-
tor our patient had for vitamin D deficiency was skin-
protective behavior that consisted of sun avoidance and 
use of SPF protection. Though vitamin D deficiency is 
commonly understood to be disproportionately repre-
sented in underserved populations (Kakarala et al. 2007), 
patients residing in northern latitudes (Webb et al. 1988), 
individuals with darker skin tones (Matsuoka et al. 1991, 
1995), the elderly (Holick et al. 2005), the obese (Worts-
man et al. 2000), and pregnant or lactating women (Lee 
et  al. 2007), its prevalence among the general popula-
tion is also increasing (Faiz et  al. 2007; Zargar et  al. 
2007). In fact, vitamin D deficiency or insufficiency is 
estimated to affect over a billion persons worldwide (Hol-
ick 2007). Increased awareness of potential dangers of 
sun exposure, skin-protective behavior, and urbanization 
of the population are thought to be some of the factors 
underlying the increase in prevalence of vitamin D defi-
ciency and insufficiency (Holick 2007). It is of note that 
this patient’s serum parathyroid hormone level was not 
checked and therefore, normocalcemic primary hyper-
parathyroidism cannot be ruled out as a contributing fac-
tor to his symptoms.
Conclusions
Our case lends support to the one presented by McCarty 
that vitamin D deficiency might be an unrecognized and 
easily reversible etiology of fatigue. Although a causal 
relationship cannot be confirmed by this case alone, the 
temporal relationship as well as biological plausibility 
makes this a possibility. While further study is needed 
to elucidate the possible mechanism for this association, 
and whether widespread screening for vitamin D defi-
ciency among patients complaining of daytime sleepi-
ness/fatigue is warranted, clinicians should consider 
obtaining serum vitamin D levels in patients who present 
with daytime sleepiness/fatigue, nonspecific musculo-
skeletal pain, and risk factors for vitamin D deficiency.
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